Yi Chen
Stock Analyst at HC Wainwright & Co.
(2.97)
# 1,220
Out of 4,829 analysts
487
Total ratings
33.47%
Success rate
1.23%
Average return
Main Sectors:
Stocks Rated by Yi Chen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CDNA CareDx | Reiterates: Neutral | $25 | $15.36 | +62.76% | 12 | May 5, 2025 | |
OKYO OKYO Pharma | Reiterates: Buy | $7 | $1.45 | +382.76% | 13 | May 5, 2025 | |
TRML Tourmaline Bio | Reiterates: Buy | $50 | $15.10 | +231.13% | 7 | May 5, 2025 | |
BLCO Bausch + Lomb | Maintains: Buy | $20 → $15 | $11.27 | +33.10% | 18 | May 2, 2025 | |
ZYXI Zynex | Maintains: Buy | $15 → $8 | $2.07 | +286.47% | 22 | Apr 30, 2025 | |
LFMD LifeMD | Reiterates: Buy | $14 | $8.26 | +69.49% | 9 | Apr 30, 2025 | |
DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $2.95 | +205.08% | 18 | Apr 29, 2025 | |
GLSI Greenwich LifeSciences | Maintains: Buy | $38 → $39 | $9.43 | +313.57% | 8 | Apr 21, 2025 | |
OCS Oculis Holding AG | Maintains: Buy | $29 → $32 | $18.58 | +72.23% | 14 | Apr 17, 2025 | |
VANI Vivani Medical | Reiterates: Buy | $4 | $1.04 | +284.62% | 5 | Apr 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.50 | +400.00% | 2 | Apr 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.84 | +160.72% | 1 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.24 | +141.94% | 14 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $9.11 | +75.63% | 10 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.51 | +166.08% | 19 | Apr 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $2.65 | +352.83% | 4 | Apr 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.42 | +338.60% | 21 | Apr 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.86 | +598.65% | 20 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.05 | +185.71% | 1 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $24.40 | +133.61% | 3 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.34 | +194.20% | 23 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.03 | +142.72% | 20 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.25 | +207.69% | 16 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $51 | $32.25 | +58.14% | 3 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.61 | +168.20% | 19 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.87 | +246.02% | 13 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $7.52 | +352.13% | 10 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $61.10 | +63.67% | 18 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.81 | +278.66% | 21 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $30 | $23.29 | +28.81% | 1 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $7.06 | +112.46% | 26 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $1.08 | +548.15% | 5 | Jan 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.50 | +495.83% | 20 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.45 | - | 10 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $75 | $0.82 | +9,035.20% | 18 | Jun 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.29 | +3,405.08% | 5 | May 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.30 | +3,530.36% | 14 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.82 | - | 7 | Jun 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $15.82 | +203.41% | 8 | Apr 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $640 | $1.08 | +59,159.26% | 5 | Apr 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $10.15 | +87.19% | 2 | Feb 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.17 | - | 2 | Apr 16, 2020 |
CareDx
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $15.36
Upside: +62.76%
OKYO Pharma
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $1.45
Upside: +382.76%
Tourmaline Bio
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $15.10
Upside: +231.13%
Bausch + Lomb
May 2, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $11.27
Upside: +33.10%
Zynex
Apr 30, 2025
Maintains: Buy
Price Target: $15 → $8
Current: $2.07
Upside: +286.47%
LifeMD
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $8.26
Upside: +69.49%
Alpha Tau Medical
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $2.95
Upside: +205.08%
Greenwich LifeSciences
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $9.43
Upside: +313.57%
Oculis Holding AG
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $18.58
Upside: +72.23%
Vivani Medical
Apr 16, 2025
Reiterates: Buy
Price Target: $4
Current: $1.04
Upside: +284.62%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.50
Upside: +400.00%
Apr 9, 2025
Initiates: Buy
Price Target: $10
Current: $3.84
Upside: +160.72%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.24
Upside: +141.94%
Apr 7, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $9.11
Upside: +75.63%
Apr 4, 2025
Reiterates: Buy
Price Target: $12
Current: $4.51
Upside: +166.08%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.65
Upside: +352.83%
Apr 4, 2025
Reiterates: Buy
Price Target: $15
Current: $3.42
Upside: +338.60%
Mar 31, 2025
Reiterates: Buy
Price Target: $6
Current: $0.86
Upside: +598.65%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $1.05
Upside: +185.71%
Mar 31, 2025
Reiterates: Buy
Price Target: $57
Current: $24.40
Upside: +133.61%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.34
Upside: +194.20%
Mar 28, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.03
Upside: +142.72%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $3.25
Upside: +207.69%
Mar 26, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $32.25
Upside: +58.14%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $2.61
Upside: +168.20%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $0.87
Upside: +246.02%
Mar 21, 2025
Reiterates: Buy
Price Target: $34
Current: $7.52
Upside: +352.13%
Mar 18, 2025
Reiterates: Buy
Price Target: $100
Current: $61.10
Upside: +63.67%
Mar 6, 2025
Reiterates: Buy
Price Target: $22
Current: $5.81
Upside: +278.66%
Mar 6, 2025
Maintains: Buy
Price Target: $27 → $30
Current: $23.29
Upside: +28.81%
Mar 4, 2025
Reiterates: Buy
Price Target: $15
Current: $7.06
Upside: +112.46%
Jan 24, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.08
Upside: +548.15%
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.50
Upside: +495.83%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.45
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $350 → $75
Current: $0.82
Upside: +9,035.20%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.29
Upside: +3,405.08%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.30
Upside: +3,530.36%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.82
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $15.82
Upside: +203.41%
Apr 1, 2021
Maintains: Buy
Price Target: $480 → $640
Current: $1.08
Upside: +59,159.26%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $10.15
Upside: +87.19%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.17
Upside: -